Migration from full to partial/no SMBG acquisition in 2009–2010 versus 2010–2011: propensity score–matched cohort
| Beneficiaries, n (%) | Mortality | |||
|---|---|---|---|---|
| n | % | |||
| TEST: 2009–2010 | ||||
| Group: | Migrating to: | |||
| Full insulin/full SMBG (n = 5,134) | Full insulin/full SMBG | 3,962 (77.1) | 295 | 7.4 |
| Full insulin/partial or no SMBG | 1,181 (22.9) | 128 | 10.8 | |
| P = 0.0002 | ||||
| NONTEST: 2009–2010 | ||||
| Group: | Migrating to: | |||
| Full insulin/full SMBG (n = 4,947) | Full insulin/full SMBG | 3,806 (76.9) | 232 | 6.1 |
| Full insulin/partial or no SMBG | 1,141 (23.1) | 106 | 9.3 | |
| P = 0.0002 | ||||
| TEST: 2010–2011 | ||||
| Group: | Migrating to: | |||
| Full insulin/full SMBG (n = 3,275) | Full insulin/full SMBG | 2,112 (64.5) | 133 | 6.3 |
| Full insulin/partial or no SMBG | 1,163 (35.5) | 102 | 8.8 | |
| P = 0.0087 | ||||
| NONTEST: 2010–2011 | ||||
| Group: | Migrating to: | |||
| Full insulin/full SMBG (n = 3,100) | Full insulin/full SMBG | 2,495 (80.5) | 143 | 5.7 |
| Full insulin/partial or no SMBG | 605 (19.5) | 60 | 9.9 | |
| P = 0.0002 | ||||
A significantly higher percentage of TEST beneficiaries than NONTEST beneficiaries migrated from full to partial/no SMBG acquisition after implementation of the CBP.